Showing results (2821-2830 of 3,018) with videos related to

Sort By:
Pageof 302
Bioorganic & Medicinal Chemistry Letters|April 20, 2005
Furanyl-1,3-thiazol-2-yl and benzoxazol-5-yl acetic acid derivatives: novel classes of heparanase inhibitorStephen M Courtney, Philip A Hay, Richard T Buck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 4, 2001
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapseE L Sievers, R A Larson, E A Stadtmauer, et al.
Blood|September 7, 2007
An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cellsMonica L Guzman, Randall M Rossi, Sundar Neelakantan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2014
Complications among adults hospitalized with influenza: a comparison of seasonal influenza and the 2009 H1N1 pandemicCarrie Reed, Sandra S Chaves, Alejandro Perez, et al.
Kidney International|February 3, 2023
Utility of new image-derived biomarkers for autosomal dominant polycystic kidney disease prognosis using automated instance cyst segmentationAdriana V Gregory, Fouad T Chebib, Bhavya Poudyal, et al.
Current Biology : CB|February 25, 2024
Organization of an ascending circuit that conveys flight motor state in DrosophilaHan S J Cheong, Kaitlyn N Boone, Marryn M Bennett, et al.
JCI Insight|August 27, 2024
miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC progressionPablo Fernández-Tussy, Magdalena P Cardelo, Hanming Zhang, et al.
Emerging Infectious Diseases|April 4, 2012
Influenza-associated hospitalizations by industry, 2009-10 influenza season, United StatesSara E Luckhaupt, Marie Haring Sweeney, Renee Funk, et al.
Blood|August 23, 2021
T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndromeDeepak Kumar, Chengyu Prince, Carolyn M Bennett, et al.
Thrombosis and Haemostasis|December 23, 2016
Long-term safety and efficacy of extended-interval prophylaxis with recombinant factor IX Fc fusion protein (rFIXFc) in subjects with haemophilia BK John Pasi, Kathelijn Fischer, Margaret Ragni, et al.
Pageof 302